entity

ZO-1

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about ZO-1: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

12Connections
0Hypotheses
1Analyses
3Outgoing
9Incoming
0Experiments
2Debates

No AI portrait yet

Outgoing (3)

TargetRelationTypeStr
benchmark_ot_ad_answer_key:ZO-1data_indataset_row0.00
h-013cc31a80targeted_byhypothesis1.00
Blood-Brain Barrier Integrityinvolved_inprocess0.80

Incoming (9)

SourceRelationTypeStr
benchmark_ot_ad_answer_key:ZO-1data_indataset_row0.00
h-013cc31a80targetshypothesis1.00
Litebamineupregulatescompound0.90
Betulinic Acidupregulatescompound0.85
CSDactivatesdrug0.80

Targeting Hypotheses (0)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
No targeting hypotheses

Mentioning Analyses (1)

Scientific analyses that reference this entity

Blood-brain barrier tight junction disruption by neuroinflammatory cytokines

neurodegeneration | 2026-04-16 | 7 hypotheses Top: 0.806

Experiments (0)

Experimental studies targeting or related to this entity

ExperimentTypeDiseaseScoreFeasibilityModelStatusEst. Cost
No experiments found

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
No papers found

Debates (2)

Multi-agent debates referencing this entity

Should PEA-PPARA endocannabinoid signaling be prioritized as a therapeutic strat

closed · Rounds: 4 · Score: 0.76 · 2026-04-23

Blood-brain barrier tight junction disruption by neuroinflammatory cytokines

closed · Rounds: 7 · Score: 0.87 · 2026-04-16

Related Research

Hypotheses and analyses mentioning ZO-1 in their description or question text

No additional research found